On Thursday in a letter to President Joe Biden, Tennessee Congressman Steve Cohen (D-TN-09) suggested there needs to be more incentive to get vaccinated instead of prioritizing unvaccinated people for monoclonal antibody treatment.Read More
Florida Gov. Ron DeSantis has spent two months cross-crossing the state promoting sites and clinics that offer monoclonal antibody treatments, an increasingly popular alternative to vaccines for protection from COVID-19.
In fact, so popular that last week, the U.S. Department of Health & Human Services (DHS), while increasing overall supplies by 50%, from 100,000 to 150,000 doses a week nationwide, but capping the number of doses being delivered to Florida and six other Southern states that had previously consumed more than 70% of the nation’s monoclonal antibody treatments.Read More
On Wednesday, Rev. Dr. Donna Whitney, Pastoral Assistant at Metropolitan Interdenominational Church in Nashville and retired Physician, spoke out against the Tennessee state’s decision to prioritize monoclonal antibody treatment for those most likely to be hospitalized rather than for whoever is in need of the treatment.Read More
Thursday morning on the Tennessee Star Report, host Michael Patrick Leahy welcomed all-star panelist Roger Simon in studio to weigh in on the distribution of monoclonal antibody treatments and free-market pharmaceutical companies.Read More
Thursday morning on the Tennessee Star Report, host Michael Patrick Leahy welcomed Senate Majority Leader Jack Johnson to the newsmakers line to weigh in on the confusion regarding monoclonal antibody treatment in Tennessee.Read More
Demand for a key COVID-19 treatment has led to a nationwide shortage, and as President Joe Biden’s administration rations how much each state receives, some governors are pushing back over having to decide how to use their limited supplies.
Many states are warning their residents that the treatment may not be available, and some are discussing offering it only to unvaccinated individuals. On Tuesday, Kentucky Gov. Andy Beshear, a Democrat, warned his states’ residents that there is “not going to be enough” of the treatment.Read More
The CEO of Tampa General Hospital has gone on the offensive, criticizing the President Joe Biden administration’s decision to ration monoclonal antibody treatments to states like Florida. The Department of Health and Humans Services (HHS) announced they will be handling the nationwide distribution of the treatments, earning much criticism from Florida officials who have been implementing the treatment for months.Read More
On Wednesday, Tennessee Representative Scott DeJarlais (R-TN-04) authored a letter to Department of Health and Human Services Secretary Xavier Becerra outlining his concerns over the new distribution protocol of monoclonal antibody therapies.Read More
Governor DeSantis announced Thursday that the 21 monoclonal antibody treatment centers he issued last month have positively resulted in a decrease in the number of hospitalizations in Florida that surged due to the COVID-19 delta variant.
Data from the Florida Hospital Association from Wednesday showed that 14,682 people were hospitalized with COVID-19 on Tuesday – a decrease of 9.9% in the last seven days.Read More
In Jacksonville and Ocala, Regeneron’s monoclonal antibody treatment sites are seeing hundreds of people receive the therapy, and it is proving successful in its early treatment phase.
Florida Gov. Ron DeSantis has been pushing for the use of the treatment for COVID patients early in their infection. The design is to receive the monoclonal treatment before serious symptoms kick in.Read More
Governor DeSantis expressed his support for Regeneron’s monoclonal antibody treatment Thursday, as COVID cases and the number of hospitalizations continue to surge in Florida.
According to DeSantis, “These treatments have been proven successful, with clinical trials resulting in a 70% reduction in hospitalization and death for COVID patients,” especially those who have higher risk for severe complications due to age or preexisting medical conditions.
As reported by the Food and Drug Administration (FDA), “Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses.” The treatment is meant for individuals who have tested positive or recovered from COVID.Read More